Seneca Therapeutics, Inc. — Form D/A
Seneca Therapeutics, Inc. of BLUE BELL, PA, a company, filed a Form D amendment with the SEC on 2022-12-23. The offering totals $12.8M, of which $7.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-12-23
- Form: D/A
- Accession: 0001778151-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.8M
- Amount sold: $7.7M
- Remaining: $5.1M
- Investors: 114
- Date of first sale: 2021-03-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-394489
Issuer
- Name: Seneca Therapeutics, Inc.
- CIK: 0001778151
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 202 ST. ANDREWS COURT, BLUE BELL, PA, 19422
- Phone: 484-883-9725
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Mark Kerschner | Executive Officer | Blue Bell, PA |
| Cuong Do | Director | DOYLESTOWN, PA |
| Cuong Do | Executive Officer | DOYLESTOWN, PA |
| Mark Kerschner | Director | Blue Bell, PA |
| Paul Hallenbeck | Director | Blue Bell, PA |
| Paul Hallenbeck | Executive Officer | Blue Bell, PA |
| James Hussey | Director | Austin, TX |
| James Hussey | Executive Officer | Austin, TX |
Other filings by this issuer (8)
More